SGS announced it has entered into collaboration with Bavarian Nordic A/S, an international biotechnology company specialising in vaccines, to develop a new respiratory syncytial virus (RSV) challenge strain. This will
SGS announced it has entered into collaboration with Bavarian Nordic A/S, an international biotechnology company specialising in vaccines, to develop a new respiratory syncytial virus (RSV) challenge strain. This will